临床肿瘤学杂志 ›› 2018, Vol. 23 ›› Issue (9): 840-844.

• 临床应用 • 上一篇    下一篇

肠外营养联合放化疗治疗上消化道恶性肿瘤的临床观察

  

  1. 050011  石家庄  石家庄市第一医院肿瘤科五病区

  • 收稿日期:2018-05-13 修回日期:2018-07-16 出版日期:2018-09-30 发布日期:2018-11-28
  • 通讯作者: 高 彤 E-mail:17773151985@163.com

Clinical observation of parenteral nutrition combined with radiotherapy and chemotherapy in the treatment of upper gastrointestinal malignant tumors

  1. 5th Ward of Oncology Department,Shijiazhuang First Hospital,Shijiazhuang 050011,China

  • Received:2018-05-13 Revised:2018-07-16 Online:2018-09-30 Published:2018-11-28
  • Contact: GAO Tong E-mail:17773151985@163.com

摘要: 目的 探讨肠外营养干预对上消化道恶性肿瘤放疗患者疗效及生活质量影响。方法 收集我院2014年11月到2017年6月间接受放化疗的上消化道恶性肿瘤患者80例,采用随机数字表法分为对照组(n=40)和观察组(n=40)。患者均给予普通调强放射治疗(IMRT)和TP方案,观察组患者于每周1至周5给予20.0%脂肪乳、复方氨基酸、10.0%葡萄糖静脉滴注,每日营养供给能量30~40 kcal/kg,至放化疗结束;对照组患者自行进食,出现黏膜反应严重或电解质紊乱时,给予对症处理。比较两组患者的近期疗效和不良反应,同时比较治疗前后的营养指标和生活质量。结果 观察组和对照组总有效率分别为90.0%和72.5%,差异具有统计学意义(P=0.042)。治疗后,观察组的Hb(109.52±6.13)g/L、ALB(31.06±3.29)g/L及TLC(2.90±0.56)×109/L均高于对照组的(98.40±6.65)g/L、(24.91±3.63)g/L、(1.81±0.52)×109/L,差异具有统计学意义(P<0.05);观察组患者的总体健康、躯体功能、社会功能、情感功能、认知功能和角色功能评分分别为66.03±7.58、 64.96±6.81、 66.18±6.23、 69.74±6.95、 63.24±6.07和65.58±6.26,均高于对照组的52.92±8.47、54.10±5.39、51.38±5.70、57.25±6.13、54.76±5.98和50.90±5.62,差异具有统计学意义 (P<0.05);治疗4周和治疗结束时,观察组患者的体质量为(66.72±5.83)kg、(65.87±5.75) kg和KPS评分为66.14±8.49 、64.93±7.74均明显高于对照组的(64.90±5.76)kg、(63.25±5.43)kg和60.78±8.63、57.86±8.20,差异具有统计学意义 (P<0.05);观察组患者3~4级消化道症状、口腔黏膜损伤、皮肤反应、贫血、血小板减少等不良反应发生例数均明显少于对照组。结论 肠道外营养能提高上消化道恶性肿瘤放化疗疗效,改善机体营养状况,降低放化疗不良反应发生,提高患者生活质量,值得在临床推广。

关键词: 上消化道恶性肿瘤, 肠外营养干预, 放化疗, 疗效, 生活质量

Abstract:

Objective To investigate the effect of parenteral nutrition intervention on the curative effect and quality of life of patients with upper gastrointestinal malignant tumor undergoing radiotherapy. Methods  Eighty patients with upper gastrointestinal malignancies who received radiotherapy and chemotherapy in our houspital from Nov. 2014 to Jun. 2017 were randomly divided into control group (n=40) and observation group (n=40). All patients were given conventional intensity modulated radiation therapy (IMRT) and TP regimen. Patients in the observation group were given intravenous drip of 20.0% fat emulsion, compound amino acid and 10.0% glucose from Monday to Friday. The daily nutritional energy was 30-40 kcal/kg until the end of radiotherapy and chemotherapy. The patients in the control group ate their own foods, and were treated with symptomatic treatment when severe mucosal reactions or electrolyte disturbances occurred. The short-term efficacy and adverse reactions of the two groups were compared, and the nutritional indicators and quality of life before and after treatment were compared. Results The total effective rates of the observation group and the control group were 90% and 72.5% respectively, and the difference was statistically significant (P=0.042). After treatment, the levels of HB, ALB and TLC in the observation group were (109.52±6.13) g/L, (31.06±3.29) g/L and TLC (2.90±0.56)×109/L higher than those in the control group(98.40±6.65) g/L, (24.91±3.63) g/L, (1.81±0.52)×109/L, respectively, and the difference was statistically significant (P<0.05). The scores of general health, physical function, social function, emotional function, cognitive function and role function in the observation group were 66.03±7.58, 64.96±6.81, 66.18±6.23, 69.74±6.95, 63.24±6.07 and 65.58±6.26 respectively, which were higher than those in the control group 52.92±8.47, 54.10±5.39, 51.38±5.70, 57.25±6.13, 54.76±5.98 and 50.90±5.62,the difference was statistically significant (P<0.05). After 4 weeks of treatment and at the end of treatment, the body mass and KPS scores of the observation group were(66.72±5.83)kg, (65.87±5.75) kg and 66.14±8.49,64.93±7.74 respectively, which were significantly higher than those of the control group (P<0.05). The number of 3-4 grade adverse reactions such as gastrointestinal symptoms, oral mucosal injury, skin reaction, anemia and thrombocytopenia in the observation group was significantly less than that in the control group. Conclusion Parenteral nutrition can improve the curative effect of radiotherapy and chemotherapy for upper gastrointestinal malignancies, improve the nutritional status of the body, reduce the occurrence of adverse reactions of radiotherapy and chemotherapy, and improve the quality of life of patients, which is worthy of clinical promotion.

Key words: Upper digestive tract malignant tumor, Parenteral nutrition intervention, Chemoradiotherapy, Curative effect, Quality of life(QoL)

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 刘锦;李贵新;马传香. 恶性黑色素瘤腹腔转移1例[J]. 临床肿瘤学杂志, 2009, 14(1): 96 .
[2] 石 玮1,华海清2,王兴华1. 放疗对肠屏障功能的影响及研究进展[J]. 临床肿瘤学杂志, 2009, 14(1): 89 .
[3] 王杰军,李 睿. NCCN成人癌痛临床实践指南解读[J]. 临床肿瘤学杂志, 2009, 14(1): 80 .
[4] 崔传亮,迟志宏,袁香庆,斯 璐,盛锡楠,郭 军. 重组人血管内皮抑制素联合化疗一线治疗晚期黑色素瘤的Ⅱ期临床研究[J]. 临床肿瘤学杂志, 2009, 14(1): 74 .
[5]

高亚杰1,关小倩1,杨海林1,张 阳2,欧阳学农3,杨建伟4,陈 焰5,徐建明6,赵宣良7,王宝成8,刘文超9,张贺龙10,南克俊11,王湘辉12

. 注射用左亚叶酸钙联合治疗晚期胃癌和结直肠癌的Ⅱ期临床研究[J]. 临床肿瘤学杂志, 2009, 14(1): 47 .
[6]  白秀丽1,马振刚1,李际君2. 紫杉醇联合卡培他滨治疗进展期胃癌的临床观察[J]. 临床肿瘤学杂志, 2009, 14(1): 68 .
[7] 徐卫国1,杨小青2,郝世柱1,宋纪宁1,张鹏东1,胡潺潺1,王文雅1. 大肠癌组织中Neuropilin-1的表达及其与肿瘤血管生成的相关性研究[J]. 临床肿瘤学杂志, 2009, 14(1): 29 .
[8] 许景艳1,欧阳建,章宜芬2,周荣富1,陈 兵1,张启国1,杨永公1,邵小雁1,徐 勇1,关朝阳1. 原发性肋骨血管肉瘤的诊治探讨[J]. 临床肿瘤学杂志, 2009, 14(1): 70 .
[9] 张艳玲,邹 岚,肖 红,黄海辉,谭崇富,阮志华,王 希,梁后杰,庞学利. 影像引导调强放射治疗鼻咽癌[J]. 临床肿瘤学杂志, 2009, 14(1): 51 .
[10] 翟云芝1,陈振东2,秦凤展1. Ezrin和AKT2在大肠癌组织中的表达及其临床意义[J]. 临床肿瘤学杂志, 2009, 14(1): 25 .